Nexien BioPharma, Inc. (NXEN)

Nexien BioPharma Balance Sheet

Financials in millions USD. Fiscal year is July - June.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020
Cash & Equivalents	0	0	0.04	0.12	0.02	0.01
Cash & Short-Term Investments	0	0	0.04	0.12	0.02	0.01
Cash Growth	-50.13%	-88.10%	-69.93%	547.96%	67.26%	-92.63%
Prepaid Expenses	-	-	0.01	0.01	0.01	0.01
Total Current Assets	0	0	0.04	0.12	0.03	0.02
Total Assets	0	0	0.04	0.12	0.03	0.02
Accounts Payable	0.07	0.05	0.02	0.02	0.01	0.02
Accrued Expenses	-	-	-	-	-	0
Short-Term Debt	0.35	0.31	0.27	0.22	0.03	0.01
Total Current Liabilities	0.42	0.37	0.3	0.24	0.04	0.03
Total Liabilities	0.42	0.37	0.3	0.24	0.04	0.03
Common Stock	0.01	0.01	0.01	0.01	0.01	0.01
Additional Paid-In Capital	11.18	11.17	10.99	10.76	10.48	11.58
Retained Earnings	-11.61	-11.53	-11.3	-10.93	-10.31	-8.45
Comprehensive Income & Other	-	-	0.05	0.05	-0.19	-3.15
Shareholders' Equity	-0.42	-0.36	-0.25	-0.12	-0.01	-0.01
Total Liabilities & Equity	0	0	0.04	0.12	0.03	0.02
Total Debt	0.35	0.31	0.27	0.22	0.03	0.01
Net Cash (Debt)	-0.35	-0.31	-0.24	-0.1	-0.01	-0
Net Cash Per Share	-0.01	-0.00	-0.00	-0.00	-0.00	-0.00
Filing Date Shares Outstanding	70.77	70.77	64.77	61.27	55.77	55.78
Total Common Shares Outstanding	70.77	70.47	64.02	60.52	55.77	53.98
Working Capital	-0.42	-0.36	-0.25	-0.12	-0.01	-0.01
Book Value Per Share	-0.01	-0.01	-0.00	-0.00	-0.00	-0.00
Tangible Book Value	-0.42	-0.36	-0.25	-0.12	-0.01	-0.01
Tangible Book Value Per Share	-0.01	-0.01	-0.00	-0.00	-0.00	-0.00

Updated Feb 14, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.